AbbVie (ABBV) Cash from Financing Activities (2016 - 2025)
AbbVie (ABBV) has disclosed Cash from Financing Activities for 14 consecutive years, with -$4.2 billion as the latest value for Q4 2025.
- Quarterly Cash from Financing Activities rose 39.28% to -$4.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$12.7 billion through Dec 2025, down 144.18% year-over-year, with the annual reading at -$12.7 billion for FY2025, 144.18% down from the prior year.
- Cash from Financing Activities for Q4 2025 was -$4.2 billion at AbbVie, up from -$4.6 billion in the prior quarter.
- The five-year high for Cash from Financing Activities was $10.8 billion in Q1 2024, with the low at -$9.6 billion in Q4 2022.
- Average Cash from Financing Activities over 5 years is -$3.9 billion, with a median of -$4.3 billion recorded in 2023.
- The sharpest move saw Cash from Financing Activities crashed 128.95% in 2021, then surged 274.73% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$6.3 billion in 2021, then crashed by 52.0% to -$9.6 billion in 2022, then surged by 53.82% to -$4.4 billion in 2023, then crashed by 54.21% to -$6.9 billion in 2024, then surged by 39.28% to -$4.2 billion in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$4.2 billion, -$4.6 billion, and -$2.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.